Want access to unlimited case records and advanced research tools? Create your free CasePortal account now. No credit card required to register.
Try CasePortal for FreeJ. Axon grants a pharmaceutical company’s motion for judgment for failure-to-warn claims brought by a patient who had breast cancer for allegations that the chemotherapy medication Taxotere resulted in her permanent hair loss. “A reasonable inquiry would have uncovered at least some information that linked Taxotere to persistent alopecia.” The patient failed to plead her fraud claims as required by the Federal Rule of Civil Procedure and products claims are time-barred.
To read this case, start your 14-day free trial.
Request a free trial account to get access to more case data, documents, and features.
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.